https://orcid.org/0009-0003-4356-4594
References
- Guimond SE , Mycroft-WestCJ, GandhiNSet al. Synthetic heparan sulfate mimetic pixatimod (PG545) potently inhibits SARS-CoV-2 by disrupting the spike-ACE2 interaction. ACS Cent. Sci.8(5), 527–545 (2022).
- Bojadzic D , AlcazarO, ChenJet al. Small-Molecule inhibitors of the coronavirus spike: ACE2 protein-protein iteraction as blockers of viral attachment and entry for SARS-CoV-2. ACS Infect. Dis.7(6), 1519–1534 (2021).
- Kuroki A , TayDJW, ChuaACYet al. Amphiphilic sulfonated polycarbonates inactivate SARS-CoV-2 in seconds. Macromolecules56(15), 6003–6009 (2023).
- Liu Y , ZhangL, YanHet al. Design of dimeric bile acid derivatives as potent and selective human NTCP inhibitors. J. Med. Chem.64(9), 5973–6007 (2021).
- Tebas P , PowderlyWG. Nelfinavir mesylate. Expert Opin. Pharmacol.1(7), 1429–1440 (2000).
- Tan GT , WickramasingheA, VermaSet al. Potential anti-AIDS naphthalenesulfonic acid derivatives. Synthesis and inhibition of HIV-1 induced cytopathogenesis and HIV-1 and HIV-2 reverse transcriptase activities. J. Med. Chem.35(26), 4846–4853 (1992).
- Mohan P , WongMF, VermaS, HuangPP, WickramasingheA, BabaM. Structure-activity relationship studies with symmetric naphthalenesulfonic acid derivatives. Synthesis and influence of spacer and naphthalenesulfonic acid moiety on anti-HIV-1 activity. J. Med. Chem.37(16), 2513–2519 (1994).
- Sepúlveda-Crespo D , dela Mata FJ, GómezR, Muñoz-FernándezMA. Sulfonate-ended carbosilane dendrimers with a flexible scaffold cause inactivation of HIV-1 virions and gp120 shedding. Nanoscale10(19), 8998–9011 (2018).
- Hong BT , ChengYE, ChengTJ, FangJM. Boronate, trifluoroborate, sulfone, sulfinate and sulfonate congeners of oseltamivir carboxylic acid: synthesis and anti-influenza activity. Eur. J. Med. Chem.163, 710–721 (2019).
- Razinkov V , GazumyanA, NikitenkoA, EllestadG, KrishnamurthyG. RFI-641 inhibits entry of respiratory syncytial virus via interactions with fusion protein. Chem. Biol.8(7), 645–659 (2001).
- He R , WangJ, YuZHet al. Structure-based design of active-site-directed, highly potent, selective, and orally bioavailable low-molecular-weight protein tyrosine phosphatase inhibitors. J. Med. Chem.65(20), 13892–13909 (2022).
- He R , WangJ, YuZHet al. Inhibition of low molecular weight protein tyrosine phosphatase by an induced-fit mechanism. J. Med. Chem.59(19), 9094–9106 (2016).
- Macedo T , Paiva-MartinsF, FerreresFet al. Anti-inflammatory effects of naringenin 8-sulphonate from parinari excelsa sabine stem bark and its semi-synthetic derivatives. Bioorg. Chem.138, doi: 10.1016/j.bioorg.2023.106614 (2023).
- Matesanz M , MensaJ. Ceftazidime-avibactam. Rev. Esp. Quimioter.34(Suppl. 1), 38–40 (2021).
- Heo YA . Imipenem/cilastatin/relebactam: a review in Gram-negative bacterial infections. Drugs81(3), 377–388 (2021).
- Büscher P , CecchiG, JamonneauV, PriottoG. Human african trypanosomiasis. Lancet390(10110), 2397–2409 (2017).
- Hawking F . Chemotherapy of onchocerciasis. Transactions of the Royal Society of Tropical Medicine. Hygiene52(2), 109–111 (1958).
- Yahi N , SabatierJM, NickelP, MabroukK, Gonzalez-ScaranoF, FantiniJ. Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells. J. Biol. Chem.269(39), 24349–24353 (1994).
- Sahu D , SarohaA, RoyS, DasS, SrivastavaPS, DasHR. Suramin ameliorates collagen induced arthritis. Int. Immunopharmacol.12(1), 288–293 (2012).
- Williams WL . The effects of suramin (germanin), azo dyes, and vasodilators on mice with transplanted lymphosarcomas. Cancer Res.6, 344–353 (1946).